Clinical Trial Update: Pilot Cohort Study of Rb-82 Myocardial PET Imaging to Evaluate Coronary Microvascular Dysfunction in Men With Prostate Cancer Receiving Androgen-Deprivation Therapy

View source ↗

Summary

This clinical trial update reports a completed pilot cohort study using Rubidium-82 myocardial PET imaging to evaluate coronary microvascular dysfunction in men…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Microvascular Dysfunction
• Prostate Cancer

Drugs mentioned

• Rubidium-82 radiotracer for PET imaging (Rubidium-82)

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Prostate Cancer | Status: COMPLETED